Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 10:00 a.m. PT on Wednesday, May 13, 2026. Peter Griffith, executive vice president and chief ...

Amgen raised its 2026 revenue and non-GAAP EPS guidance after a strong first quarter, driven by 24% growth from six key products. The company expanded its MariTide Phase III program to include ...

Amgen Inc. (NASDAQ:AMGN) is included among the 13 NASDAQ Stocks with Highest Dividends. On April 10, Morgan Stanley analyst Terence Flynn raised the firm’s price recommendation on Amgen Inc.

Amgen Inc (AMGN) reports a robust 4% growth in product sales, driven by key growth drivers, while navigating patent expirations and increased competition.

Bio-Rad Laboratories lowered its 2026 revenue growth outlook to between -3% and +0.5% due to Middle East disruptions, while Amgen raised its full-year revenue and EPS guidance on strong product ...